State of the Art ReviewCancer

On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation

See allHide authors and affiliations

Science Translational Medicine  25 Mar 2015:
Vol. 7, Issue 280, pp. 280sr1
DOI: 10.1126/scitranslmed.3010274

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article